|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Exelixis, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... option to co-develop and co-commercialize XL413. XL888: XL888 is a synthetic inhibitor of HSP90, a chaperone protein ... Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review ... treatment of advanced solid malignancies and XL888, an ATP-competitive inhibitor of HSP90, and ... |